Adaptilens is a startup based in the United States, most recent round Series A.
Based in the United States, Adaptilens is a startup. Its most recent tracked round is Series A.
Adaptilens develops a biomimetic accommodating intraocular lens (A-IOL) designed to restore the eye's natural ability to focus over a range of distances by replacing the cataractous lens with a soft, flexible lens that responds to the eye's muscles.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.